Copyright Reports & Markets. All rights reserved.

Global (United States, European Union and China) Dendritic Cell Cancer Vaccine Market Research Report 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Major Manufacturers Covered in This Report
    • 1.3 Market Segment by Type
      • 1.3.1 Global Dendritic Cell Cancer Vaccine Market Size Growth Rate by Type (2019-2025)
      • 1.3.2 CreaVax
      • 1.3.3 Sipuleucel-T (Provenge)
      • 1.3.4 Others
    • 1.4 Market Segment by Application
      • 1.4.1 Global Dendritic Cell Cancer Vaccine Market Share by Application (2019-2025)
      • 1.4.2 Pediatrics
      • 1.4.3 Adults
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Global Growth Trends

    • 2.1 Global Dendritic Cell Cancer Vaccine Market Size
      • 2.1.1 Global Dendritic Cell Cancer Vaccine Revenue 2014-2025
      • 2.1.2 Global Dendritic Cell Cancer Vaccine Sales 2014-2025
    • 2.2 Dendritic Cell Cancer Vaccine Growth Rate by Regions
      • 2.2.1 Global Dendritic Cell Cancer Vaccine Sales by Regions 2014-2019
      • 2.2.2 Global Dendritic Cell Cancer Vaccine Revenue by Regions 2014-2019
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers

    3 Market Share by Manufacturers

    • 3.1 Dendritic Cell Cancer Vaccine Sales by Manufacturers
      • 3.1.1 Dendritic Cell Cancer Vaccine Sales by Manufacturers 2014-2019
      • 3.1.2 Dendritic Cell Cancer Vaccine Sales Market Share by Manufacturers 2014-2019
    • 3.2 Revenue by Manufacturers
      • 3.2.1 Dendritic Cell Cancer Vaccine Revenue by Manufacturers (2014-2019)
      • 3.2.2 Dendritic Cell Cancer Vaccine Revenue Share by Manufacturers (2014-2019)
      • 3.2.3 Global Dendritic Cell Cancer Vaccine Market Concentration Ratio (CR5 and HHI)
    • 3.3 Dendritic Cell Cancer Vaccine Price by Manufacturers
    • 3.4 Key Manufacturers Dendritic Cell Cancer Vaccine Plants/Factories Distribution and Area Served
    • 3.5 Date of Key Manufacturers Enter into Dendritic Cell Cancer Vaccine Market
    • 3.6 Key Manufacturers Dendritic Cell Cancer Vaccine Product Offered
    • 3.7 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Sales and Revenue for Each Type
      • 4.1.1 CreaVax Sales and Revenue (2014-2019)
      • 4.1.2 Sipuleucel-T (Provenge) Sales and Revenue (2014-2019)
      • 4.1.3 Others Sales and Revenue (2014-2019)
    • 4.2 Global Dendritic Cell Cancer Vaccine Sales Market Share by Type
    • 4.3 Global Dendritic Cell Cancer Vaccine Revenue Market Share by Type
    • 4.4 Dendritic Cell Cancer Vaccine Price by Type

    5 Market Size by Application

    • 5.1 Overview
    • 5.2 Global Dendritic Cell Cancer Vaccine Sales by Application

    6 United States

    • 6.1 United States Dendritic Cell Cancer Vaccine Breakdown Data by Company
    • 6.2 United States Dendritic Cell Cancer Vaccine Breakdown Data by Type
    • 6.3 United States Dendritic Cell Cancer Vaccine Breakdown Data by Application

    7 European Union

    • 7.1 European Union Dendritic Cell Cancer Vaccine Breakdown Data by Company
    • 7.2 European Union Dendritic Cell Cancer Vaccine Breakdown Data by Type
    • 7.3 European Union Dendritic Cell Cancer Vaccine Breakdown Data by Application

    8 China

    • 8.1 China Dendritic Cell Cancer Vaccine Breakdown Data by Company
    • 8.2 China Dendritic Cell Cancer Vaccine Breakdown Data by Type
    • 8.3 China Dendritic Cell Cancer Vaccine Breakdown Data by Application

    9 Rest of World

    • 9.1 Rest of World Dendritic Cell Cancer Vaccine Breakdown Data by Company
    • 9.2 Rest of World Dendritic Cell Cancer Vaccine Breakdown Data by Type
    • 9.3 Rest of World Dendritic Cell Cancer Vaccine Breakdown Data by Application
    • 9.4 Rest of World Dendritic Cell Cancer Vaccine Breakdown Data by Countries
      • 9.4.1 Rest of World Dendritic Cell Cancer Vaccine Sales by Countries
      • 9.4.2 Rest of World Dendritic Cell Cancer Vaccine Revenue by Countries
      • 9.4.3 Japan
      • 9.4.4 Korea
      • 9.4.5 India
      • 9.4.6 Southeast Asia

    10 Company Profiles

    • 10.1 Medigene
      • 10.1.1 Medigene Company Details
      • 10.1.2 Company Description and Business Overview
      • 10.1.3 Sales, Revenue and Market Share of Dendritic Cell Cancer Vaccine
      • 10.1.4 Dendritic Cell Cancer Vaccine Product Introduction
      • 10.1.5 Medigene Recent Development
    • 10.2 Activarti
      • 10.2.1 Activarti Company Details
      • 10.2.2 Company Description and Business Overview
      • 10.2.3 Sales, Revenue and Market Share of Dendritic Cell Cancer Vaccine
      • 10.2.4 Dendritic Cell Cancer Vaccine Product Introduction
      • 10.2.5 Activarti Recent Development
    • 10.3 Argos Therapeutics
      • 10.3.1 Argos Therapeutics Company Details
      • 10.3.2 Company Description and Business Overview
      • 10.3.3 Sales, Revenue and Market Share of Dendritic Cell Cancer Vaccine
      • 10.3.4 Dendritic Cell Cancer Vaccine Product Introduction
      • 10.3.5 Argos Therapeutics Recent Development
    • 10.4 Batavia Bioservices
      • 10.4.1 Batavia Bioservices Company Details
      • 10.4.2 Company Description and Business Overview
      • 10.4.3 Sales, Revenue and Market Share of Dendritic Cell Cancer Vaccine
      • 10.4.4 Dendritic Cell Cancer Vaccine Product Introduction
      • 10.4.5 Batavia Bioservices Recent Development
    • 10.5 Bellicum Pharmaceuticals
      • 10.5.1 Bellicum Pharmaceuticals Company Details
      • 10.5.2 Company Description and Business Overview
      • 10.5.3 Sales, Revenue and Market Share of Dendritic Cell Cancer Vaccine
      • 10.5.4 Dendritic Cell Cancer Vaccine Product Introduction
      • 10.5.5 Bellicum Pharmaceuticals Recent Development
    • 10.6 Creagene
      • 10.6.1 Creagene Company Details
      • 10.6.2 Company Description and Business Overview
      • 10.6.3 Sales, Revenue and Market Share of Dendritic Cell Cancer Vaccine
      • 10.6.4 Dendritic Cell Cancer Vaccine Product Introduction
      • 10.6.5 Creagene Recent Development
    • 10.7 DanDrit Biotech
      • 10.7.1 DanDrit Biotech Company Details
      • 10.7.2 Company Description and Business Overview
      • 10.7.3 Sales, Revenue and Market Share of Dendritic Cell Cancer Vaccine
      • 10.7.4 Dendritic Cell Cancer Vaccine Product Introduction
      • 10.7.5 DanDrit Biotech Recent Development
    • 10.8 DCPrime
      • 10.8.1 DCPrime Company Details
      • 10.8.2 Company Description and Business Overview
      • 10.8.3 Sales, Revenue and Market Share of Dendritic Cell Cancer Vaccine
      • 10.8.4 Dendritic Cell Cancer Vaccine Product Introduction
      • 10.8.5 DCPrime Recent Development
    • 10.9 Sanpower Corporation (Dendreon)
      • 10.9.1 Sanpower Corporation (Dendreon) Company Details
      • 10.9.2 Company Description and Business Overview
      • 10.9.3 Sales, Revenue and Market Share of Dendritic Cell Cancer Vaccine
      • 10.9.4 Dendritic Cell Cancer Vaccine Product Introduction
      • 10.9.5 Sanpower Corporation (Dendreon) Recent Development
    • 10.10 Elios Therapeutics
      • 10.10.1 Elios Therapeutics Company Details
      • 10.10.2 Company Description and Business Overview
      • 10.10.3 Sales, Revenue and Market Share of Dendritic Cell Cancer Vaccine
      • 10.10.4 Dendritic Cell Cancer Vaccine Product Introduction
      • 10.10.5 Elios Therapeutics Recent Development
    • 10.11 Immunicum
    • 10.12 Kiromic
    • 10.13 Merck
    • 10.14 Northwest Biotherapeutics
    • 10.15 Glaxo Smith Kline
    • 10.16 ImmunoCellular
    • 10.17 Tella
    • 10.18 Vaxil Bio
    • 10.19 Medigene

    11 Value Chain and Sales Channels Analysis

    • 11.1 Value Chain Analysis
    • 11.2 Sales Channels Analysis
      • 11.2.1 Dendritic Cell Cancer Vaccine Sales Channels
      • 11.2.2 Dendritic Cell Cancer Vaccine Distributors
    • 11.3 Dendritic Cell Cancer Vaccine Customers

    12 Market Forecast

    • 12.1 Global Dendritic Cell Cancer Vaccine Sales and Revenue Forecast 2019-2025
    • 12.2 Global Dendritic Cell Cancer Vaccine Sales Forecast by Type
    • 12.3 Global Dendritic Cell Cancer Vaccine Sales Forecast by Application
    • 12.4 Dendritic Cell Cancer Vaccine Forecast by Regions
      • 12.4.1 Global Dendritic Cell Cancer Vaccine Sales Forecast by Regions 2019-2025
      • 12.4.2 Global Dendritic Cell Cancer Vaccine Revenue Forecast by Regions 2019-2025
    • 12.5 United States Market Forecast
    • 12.6 European Union Market Forecast
    • 12.7 China Market Forecast
    • 12.8 Rest of World
      • 12.8.1 Japan
      • 12.8.2 Korea
      • 12.8.3 India

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Research Methodology
        • 14.1.1 Methodology/Research Approach
          • 14.1.1.1 Research Programs/Design
          • 14.1.1.2 Market Size Estimation
          • 14.1.1.3 Market Breakdown and Data Triangulation
        • 14.1.2 Data Source
          • 14.1.2.1 Secondary Sources
          • 14.1.2.2 Primary Sources
      • 14.2 Author Details

      Dendritic cells (DCs) refer to rare kind of leukocytes. They have prompted their recent application to therapeutic cancer vaccinations as they are uniquely effective in their ability to present antigens to T cells.
      In 2019, the market size of Dendritic Cell Cancer Vaccine is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
      In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Dendritic Cell Cancer Vaccine.

      This report studies the global market size of Dendritic Cell Cancer Vaccine, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
      This study presents the Dendritic Cell Cancer Vaccine sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
      For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

      In global market, the following companies are covered:
      Medigene
      Activarti
      Argos Therapeutics
      Batavia Bioservices
      Bellicum Pharmaceuticals
      Creagene
      DanDrit Biotech
      DCPrime
      Sanpower Corporation (Dendreon)
      Elios Therapeutics
      Immunicum
      Kiromic
      Merck
      Northwest Biotherapeutics
      Glaxo Smith Kline
      ImmunoCellular
      Tella
      Vaxil Bio
      Medigene

      Market Segment by Product Type
      CreaVax
      Sipuleucel-T (Provenge)
      Others

      Market Segment by Application
      Pediatrics
      Adults

      Key Regions split in this report: breakdown data for each region.
      United States
      China
      European Union
      Rest of World (Japan, Korea, India and Southeast Asia)

      The study objectives are:
      To analyze and research the Dendritic Cell Cancer Vaccine status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
      To present the key Dendritic Cell Cancer Vaccine manufacturers, presenting the sales, revenue, market share, and recent development for key players.
      To split the breakdown data by regions, type, companies and applications
      To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
      To identify significant trends, drivers, influence factors in global and regions
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

      In this study, the years considered to estimate the market size of Dendritic Cell Cancer Vaccine are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      Buy now